NCT07071974View on ClinicalTrials.gov

A Study in Healthy People to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

July 28, 2025

Primary Completion Date

October 7, 2025

Study Completion Date

October 14, 2025

Conditions
Healthy
Interventions
DRUG

BI 456906 formulation A

BI 456906 formulation A

DRUG

BI 456906 formulation B2

BI 456906 formulation B2

Trial Locations (1)

13627

CRS Clinical Research Services Berlin GmbH, Berlin

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY